113 related articles for article (PubMed ID: 29189509)
41. MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.
Cordas Dos Santos DM; Eilers J; Sosa Vizcaino A; Orlova E; Zimmermann M; Stanulla M; Schrappe M; Börner K; Grimm D; Muckenthaler MU; Kulozik AE; Kunz JB
BMC Cancer; 2018 Jun; 18(1):663. PubMed ID: 29914415
[TBL] [Abstract][Full Text] [Related]
42. [Gene rearrangement pattern of immunoglobulin and T-cell receptor (Ig/TR) and its clinical characteristics in children with SET-NUP214 fusion gene-positive leukemia/lymphoma].
Li WJ; Cui L; Gao C; Zhao XX; Liu SG; Xin YP; Zhang RD; Zhang DW; Wang B; Li ZG; Wu MY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1362-7. PubMed ID: 22169284
[TBL] [Abstract][Full Text] [Related]
43. [T-cell acute lymphoblastic leukemia].
Yokoyama H; Usui N
Gan To Kagaku Ryoho; 2009 May; 36(5):749-51. PubMed ID: 19499601
[No Abstract] [Full Text] [Related]
44. Clinical outcome of childhood lymphoblastic lymphoma in Shanghai China 2001-2010.
Gao YJ; Pan C; Tang JY; Lu FJ; Chen J; Xue HL; Zhai XW; Li J; Ye QD; Zhou M; Wang HS; Miao H; Qian XW; Xu Z; Meng JH
Pediatr Blood Cancer; 2014 Apr; 61(4):659-63. PubMed ID: 24243691
[TBL] [Abstract][Full Text] [Related]
45. Impact of TCF3 rearrangement on CNS relapse in egyptian pediatric acute lymphoblastic leukemia.
ElGendi HM; Abdelmaksoud AA; Eissa DG; Abusikkien SA
Pediatr Hematol Oncol; 2014 Oct; 31(7):638-46. PubMed ID: 25116187
[TBL] [Abstract][Full Text] [Related]
46. Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols.
Michaux K; Bergeron C; Gandemer V; Mechinaud F; Uyttebroeck A; Bertrand Y;
Pediatr Blood Cancer; 2016 Jul; 63(7):1214-21. PubMed ID: 27037853
[TBL] [Abstract][Full Text] [Related]
47. The activating STAT5B N642H mutation is a common abnormality in pediatric T-cell acute lymphoblastic leukemia and confers a higher risk of relapse.
Bandapalli OR; Schuessele S; Kunz JB; Rausch T; Stütz AM; Tal N; Geron I; Gershman N; Izraeli S; Eilers J; Vaezipour N; Kirschner-Schwabe R; Hof J; von Stackelberg A; Schrappe M; Stanulla M; Zimmermann M; Koehler R; Avigad S; Handgretinger R; Frismantas V; Bourquin JP; Bornhauser B; Korbel JO; Muckenthaler MU; Kulozik AE
Haematologica; 2014 Oct; 99(10):e188-92. PubMed ID: 24972766
[No Abstract] [Full Text] [Related]
48. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
[TBL] [Abstract][Full Text] [Related]
49. Pediatric T-cell lymphoblastic leukemia evolves into relapse by clonal selection, acquisition of mutations and promoter hypomethylation.
Kunz JB; Rausch T; Bandapalli OR; Eilers J; Pechanska P; Schuessele S; Assenov Y; Stütz AM; Kirschner-Schwabe R; Hof J; Eckert C; von Stackelberg A; Schrappe M; Stanulla M; Koehler R; Avigad S; Elitzur S; Handgretinger R; Benes V; Weischenfeldt J; Korbel JO; Muckenthaler MU; Kulozik AE
Haematologica; 2015 Nov; 100(11):1442-50. PubMed ID: 26294725
[TBL] [Abstract][Full Text] [Related]
50. ALL-REZ BFM--the consecutive trials for children with relapsed acute lymphoblastic leukemia.
Henze G; v Stackelberg A; Eckert C
Klin Padiatr; 2013 May; 225 Suppl 1():S73-8. PubMed ID: 23700062
[TBL] [Abstract][Full Text] [Related]
51. Outcome of children and adolescents with a second or third relapse of acute lymphoblastic leukemia (ALL): a population-based analysis of the Austrian ALL-BFM (Berlin-Frankfurt-Münster) study group.
Reismüller B; Peters C; Dworzak MN; Pötschger U; Urban C; Meister B; Schmitt K; Dieckmann K; Gadner H; Attarbaschi A; Mann G;
J Pediatr Hematol Oncol; 2013 Jul; 35(5):e200-4. PubMed ID: 23652878
[TBL] [Abstract][Full Text] [Related]
52. Long-term results of Taiwan Pediatric Oncology Group studies 1997 and 2002 for childhood acute lymphoblastic leukemia.
Liang DC; Yang CP; Lin DT; Hung IJ; Lin KH; Chen JS; Hsiao CC; Chang TT; Peng CT; Lin MT; Chang TK; Jaing TH; Liu HC; Wang LY; Yeh TC; Jou ST; Lu MY; Cheng CN; Sheen JM; Chiou SS; Wu KH; Hung GY; Chen RL; Chen SH; Cheng SN; Chang YH; Chen BW; Ho WL; Wang JL; Lin ST; Hsieh YL; Wang SC; Chang HH; Yang YL; Huang FL; Chang CY; Chang WH; Lin KS
Leukemia; 2010 Feb; 24(2):397-405. PubMed ID: 20016538
[TBL] [Abstract][Full Text] [Related]
53. Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells.
Martelli AM; Lonetti A; Buontempo F; Ricci F; Tazzari PL; Evangelisti C; Bressanin D; Cappellini A; Orsini E; Chiarini F
Adv Biol Regul; 2014 Sep; 56():6-21. PubMed ID: 24819383
[TBL] [Abstract][Full Text] [Related]
54. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
55. hTERT promoter methylation and telomere length in childhood acute lymphoblastic leukemia: associations with immunophenotype and cytogenetic subgroup.
Borssén M; Cullman I; Norén-Nyström U; Sundström C; Porwit A; Forestier E; Roos G
Exp Hematol; 2011 Dec; 39(12):1144-51. PubMed ID: 21914494
[TBL] [Abstract][Full Text] [Related]
56. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
Sun C; Chang L; Zhu X
Oncotarget; 2017 May; 8(21):35445-35459. PubMed ID: 28418909
[TBL] [Abstract][Full Text] [Related]
57. An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
Bond J; Marchand T; Touzart A; Cieslak A; Trinquand A; Sutton L; Radford-Weiss I; Lhermitte L; Spicuglia S; Dombret H; Macintyre E; Ifrah N; Hamel JF; Asnafi V
Haematologica; 2016 Jun; 101(6):732-40. PubMed ID: 26944475
[TBL] [Abstract][Full Text] [Related]
58. Novel t(2;12)(q31;p13) in a case of pediatric T-cell acute lymphoblastic leukemia.
Parihar M; Gupta A; Remani AS; Bhattacharyya A; Mishra DK; Chandy M
J Pediatr Hematol Oncol; 2014 Jul; 36(5):e313-5. PubMed ID: 24577543
[TBL] [Abstract][Full Text] [Related]
59. Flow cytometric minimal residual disease assessment of peripheral blood in acute lymphoblastic leukaemia patients has potential for early detection of relapsed extramedullary disease.
Keegan A; Charest K; Schmidt R; Briggs D; Deangelo DJ; Li B; Morgan EA; Pozdnyakova O
J Clin Pathol; 2018 Jul; 71(7):653-658. PubMed ID: 29588374
[TBL] [Abstract][Full Text] [Related]
60. Novel biological insights in T-cell acute lymphoblastic leukemia.
Durinck K; Goossens S; Peirs S; Wallaert A; Van Loocke W; Matthijssens F; Pieters T; Milani G; Lammens T; Rondou P; Van Roy N; De Moerloose B; Benoit Y; Haigh J; Speleman F; Poppe B; Van Vlierberghe P
Exp Hematol; 2015 Aug; 43(8):625-39. PubMed ID: 26123366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
